Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Elanco Animal Health Incorporated (ELAN)

10.96   -0.28 (-2.49%) 10-02 16:00
Open: 11.22 Pre. Close: 11.24
High: 11.22 Low: 10.879
Volume: 3,486,601 Market Cap: 5,400(M)

Technical analysis

as of: 2023-10-02 4:49:46 PM
Short-term rate:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Mid-term rate:       
Target: Six months: 13.99     One year: 14.79
Support: Support1: 10.87    Support2: 9.05
Resistance: Resistance1: 11.98    Resistance2: 12.67
Pivot: 11.49
Moving Average: MA(5): 11.17     MA(20): 11.57
MA(100): 10.74     MA(250): 11.28
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 14.6     %D(3): 15.7
RSI: RSI(14): 36.8
52-week: High: 14.68  Low: 7.88
Average Vol(K): 3-Month: 5,485 (K)  10-Days: 3,330 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ELAN ] has closed above bottom band by 8.6%. Bollinger Bands are 13.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.23 - 11.29 11.29 - 11.34
Low: 10.74 - 10.81 10.81 - 10.86
Close: 10.85 - 10.96 10.96 - 11.06

Company Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Headline News

Mon, 02 Oct 2023
SG Americas Securities LLC Purchases Shares of 24369 Elanco ... - MarketBeat

Sat, 23 Sep 2023
First-of-its-kind parvo treatment may revolutionize care for highly ... - USA TODAY

Fri, 22 Sep 2023
Sciencast Management LP Acquires Stake in Elanco Animal Health ... - Best Stocks

Tue, 19 Sep 2023
New Strong Buy Stocks for September 19th - Nasdaq

Fri, 15 Sep 2023
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by ... - MarketBeat

Sun, 10 Sep 2023
Franklin Resources Inc. Significantly Reduces Stake in Elanco ... - Best Stocks

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 493 (M)
Shares Float 491 (M)
% Held by Insiders 0.5 (%)
% Held by Institutions 100.7 (%)
Shares Short 10,360 (K)
Shares Short P.Month 10,140 (K)

Stock Financials

EPS -0.22
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 15.06
Profit Margin (%) -2.7
Operating Margin (%) 8.2
Return on Assets (ttm) 1.4
Return on Equity (ttm) -1.6
Qtrly Rev. Growth -10
Gross Profit (p.s.) 5.07
Sales Per Share 8.76
EBITDA (p.s.) 1.97
Qtrly Earnings Growth 0
Operating Cash Flow 118 (M)
Levered Free Cash Flow 88 (M)

Stock Valuations

PE Ratio -49.82
PEG Ratio -66.7
Price to Book value 0.72
Price to Sales 1.24
Price to Cash Flow 45.76

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.